Mazor Robotics (NASDAQ:MZOR) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday.
MZOR has been the subject of several other research reports. Zacks Investment Research lowered Mazor Robotics from a “buy” rating to a “hold” rating in a report on Saturday, January 13th. Vetr lowered Mazor Robotics from a “hold” rating to a “sell” rating and set a $66.27 price objective for the company. in a report on Thursday, March 8th. Finally, Barclays reissued a “sell” rating and issued a $36.00 price objective on shares of Mazor Robotics in a report on Tuesday, January 9th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Mazor Robotics presently has an average rating of “Hold” and an average target price of $48.75.
Shares of Mazor Robotics (NASDAQ MZOR) traded down $0.63 on Wednesday, reaching $72.14. The company had a trading volume of 386,820 shares, compared to its average volume of 540,606. Mazor Robotics has a 52 week low of $22.58 and a 52 week high of $76.56. The stock has a market cap of $1,909.56, a price-to-earnings ratio of -141.45 and a beta of 1.18.
Hedge funds have recently bought and sold shares of the business. IFP Advisors Inc grew its holdings in Mazor Robotics by 87.2% during the 4th quarter. IFP Advisors Inc now owns 2,275 shares of the medical instruments supplier’s stock valued at $117,000 after buying an additional 1,060 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in Mazor Robotics by 72.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 2,659 shares of the medical instruments supplier’s stock valued at $137,000 after buying an additional 1,117 shares in the last quarter. Advisor Group Inc. grew its holdings in Mazor Robotics by 365.8% during the 3rd quarter. Advisor Group Inc. now owns 2,795 shares of the medical instruments supplier’s stock valued at $138,000 after buying an additional 2,195 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. grew its holdings in Mazor Robotics by 107.3% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,811 shares of the medical instruments supplier’s stock valued at $188,000 after buying an additional 1,973 shares in the last quarter. Finally, Stratos Wealth Partners LTD. purchased a new position in Mazor Robotics during the 3rd quarter valued at about $216,000. 24.09% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Mazor Robotics (MZOR) Upgraded to “Strong-Buy” at BidaskClub” was published by American Banking News and is owned by of American Banking News. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/14/mazor-robotics-mzor-upgraded-to-strong-buy-at-bidaskclub.html.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.